GENECAST CO LTD has a total of 21 patent applications. It increased the IP activity by 350.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, foods and drinks and measurement are UNIV AUTÓNOMA DE NUEVO LEÓN, VALIGENE CORP and BOREAL PLANT BREEDING LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | China | 2 | |
#4 | Taiwan | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Enzymes | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lee Byung Chul | 19 |
#2 | Park Il Hyun | 15 |
#3 | Lee Huy Ho | 13 |
#4 | Choi Ji Hyeon | 4 |
#5 | Lee Byung-Chul | 2 |
#6 | Park Han Bi | 2 |
#7 | Park Il-Hyun | 2 |
#8 | Park Ji Eun | 2 |
#9 | Lee Huy-Ho | 2 |
#10 | Park Hong Marn | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200087723A | DNA polymerase for detecting EGFR mutation and kit comprising the same | |
WO2020145734A1 | Dna polymerase for detecting braf mutations, and kit comprising same | |
KR20200087726A | DNA polymerase for detecting TERT mutation and kit comprising the same | |
KR20200087725A | DNA polymerase for detecting JAK2 mutation and kit comprising the same | |
WO2020145754A1 | Mass spectrometry using dna polymerase with increased genetic mutation specificity | |
US2020149018A1 | Dna polymerase with increased gene mutation specificty and pcr buffer composition for increasing activity thereof | |
KR20190007216A | Pcr buffer compositions for increasing activity of dna polymerases with increased mutation specificity | |
KR20190007214A | Dna polymerases with increased mutation specific amplification |